Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preemptive oxycodone dosing for analgesia and inflammatory response in thoracoscopic lung surgery
ChiCTR2500112478Phase 4Not yet recruiting
- Sponsor
- The Second Affiliated Hospital of Shantou University Medical College
- Start
- Nov 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of oxycodone in postoperative pain (5 arms), sponsored by The Second Affiliated Hospital of Shantou University Medical College. Primary endpoint: Postoperative VAS score changes. Planned start Nov 2025; status: not yet recruiting.
02
Drugs
oxycodone
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR2500112478.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500112478.